The global probiotics market was valued at USD 48.88 billion in 2019 and is expected to reach USD 94.48 billion by 2027, registering a CAGR of 7.9% over the forecast period. In 2019, North America led the market, accounting for 16.98% of the global share. The U.S. probiotics market is projected to witness significant growth, reaching an estimated USD 17.99 billion by 2032, driven by the increasing adoption of immunity-boosting and probiotic-fortified food products due to their health benefits.
Growing consumer awareness of preventive healthcare, along with rising demand for natural and safe health-enhancing products, is expected to fuel market expansion. Additionally, various initiatives by professional organizations aimed at educating consumers and promoting probiotic consumption will further support growth. For example, the Nutrition Society of Malaysia (NSM) has launched the Probiotics Education Program (PEP) to enhance consumer knowledge about the health benefits of probiotics.
Information Source: https://www.fortunebusinessinsights.com/industry-reports/probiotics-market-100083
What Does the Report Include?
The market report provides a comprehensive analysis of key growth drivers, restraints, opportunities, and challenges expected to impact the market during the forecast period. Additionally, it offers an in-depth examination of regional market trends influencing overall growth. Our research analysts, leveraging insights from industry experts and various methodologies, have compiled this data. The report also explores the competitive landscape, detailing strategies such as product launches, partnerships, mergers, acquisitions, and collaborations that companies employ to strengthen their market position from 2020 to 2027.
DRIVING FACTORS
Rising Demand for Immunity-Boosting Foods to Drive Market Growth
The increasing prevalence of lifestyle diseases, including obesity and diabetes, is fueling demand for healthier dietary choices. According to the World Health Organization (WHO), global obesity rates have tripled since 1975. This alarming trend has accelerated the demand for immunity-enhancing products such as probiotics worldwide. Additionally, advancements in technology are enabling manufacturers to educate consumers about the health benefits of these products, further driving market expansion. These factors are expected to propel the growth of the global probiotic bacteria market over the forecast period.
SEGMENTATION
Supermarkets/Hypermarkets Accounted for 61.33% Market Share in 2019
In 2019, the supermarkets/hypermarkets segment held a dominant market share of 61.33%. This growth is attributed to the broad availability of products, easy accessibility, and attractive incentives such as discounts and cashback offers.
REGIONAL INSIGHTS
Asia-Pacific to Lead Market Growth Due to Increased Consumption of Fermented Beverages
Asia-Pacific is projected to experience significant growth and maintain a leading position in the global probiotic bacteria market. This dominance is primarily driven by the rising consumption of fermented food products, which contribute to gut health and a well-balanced diet.
Meanwhile, the North American market, valued at USD 8.30 billion in 2019, is expected to witness substantial growth during the forecast period. This growth is attributed to the rising incidence of lifestyle-related diseases and the presence of established manufacturers focused on developing innovative probiotic products between 2020 and 2027.
COMPETITIVE LANDSCAPE
Leading Companies Focus on Innovation to Strengthen Market Presence
The global probiotics market comprises several key players striving to expand their presence by introducing new and innovative probiotic products. Strategic initiatives such as partnerships, collaborations, and mergers and acquisitions are being adopted by these companies to enhance their distribution networks and drive market growth.
List of the Companies Profiled in the Market:
- Danone S.A. (Paris, France)
- Lallemand Inc. (Canada)
- Yakult Honsha (Japan)
- Nestlé S.A. (Vevey, Swizerland)
- DuPont (Danisco A/S) (Delaware, United States)
- Hansen (Horsholm, Denmark)
- Kerry Inc. (Tralee, Ireland)
- Post Holdings, Inc. (Missouri)
- Pepsico, Inc. (New York, United States)
- Evolve Biosystems, Inc. (Davis, California)
Industry Development:
- June 2020 – Pendulum Therapeutics launched Pendulum Glucose Control, the first-ever medical probiotic proven to reduce blood sugar spikes and A1C levels.